graphic
Markets & Stocks
Biotech sickens Nasdaq
March 14, 2000: 5:23 p.m. ET

Plan to open the gene map sparks sell-off that spreads to broad market
By Staff Writer Jake Ulick
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - The Nasdaq composite index plunged for the second straight session Tuesday and posted its second-worst point loss on record, hurt by biotechnology stocks, which crumbled after President Clinton proposed making gene mapping data public.
    The proposal by the U.S. and British governments sparked fears that free data would hurt profits in the high-flying sector.
    The Nasdaq composite fell 200.19 points, or 4.1 percent, to 4,707.05, bringing its two-day loss to more than 341 points, or 6.7 percent.
    "The market was doing OK until the biotechs got slammed," said Al Goldman, chief market strategist at A.G. Edwards.
    graphicThe nervousness spread to other indexes. The Dow Jones industrial average shed 135.89, or 1.4 percent, to 9,811.24, paring earlier gains that pushed the gauge above the 10,000 mark.
    The broader S&P 500 lost 24.47, or 1.8 percent, to 1,359.15.
    More stocks fell than rose. Declining issues on the New York Stock Exchange outpaced advancing ones 1,702 to 1,288. Volume topped 1 billion shares. Nasdaq losers beat winners 2,792 to 1,501. More than 1.9 billion shares changed hands. graphic
    In other markets, the dollar fell against the yen and euro. Treasury securities rose.
    
Biotechs lead downward spiral

    Biotech stocks have soared recently as investors chased the latest in medical breakthroughs. The Nasdaq Biotech Index jumped about 100 percent in 1999, and has gained as much as 60 percent this year.
    Tuesday's gene map news jolted that trend.
    "Biotech is weak and biotech has been one of the main reasons that led the Nasdaq to 5,000," said Kenneth Sheinberg, head of listed trading at SG Cowen.
    The Nasdaq closed above 5,000 for the first time Thursday.
    Among the losers, Human Genome Sciences  (HGSI: Research, Estimates) tumbled 29-1/16 to 123-1/2, Amgen (AMGN: Research, Estimates) fell 5-3/4 to 52-1/4, Genzyme (GENZ: Research, Estimates) dropped 5-1/2 to 46-7/16, and Immunex (IMNX: Research, Estimates) lost 31-7/16 to 153-15/16.
    On the NYSE, Celera Genomics (CRA: Research, Estimates) skidded 39-1/4 to 149-1/4.
    As such, Barry Hyman, chief market strategist at Ehrenkrantz King Nussbaum, says now may be a buying opportunity.
    "Biotechnology is not going away and if investors are looking for an entry point, this might be it," Hyman told CNNfn's Talking Stocks.
    But biotech stocks weren't the only losers. Microsoft (MSFT: Research, Estimates) fell 2-7/8 to 95-1/8, Cisco Systems (CSCO: Research, Estimates) shed 4-7/16 to 131-3/4 and Intel (INTC: Research, Estimates) lost 4-1/2 to 117-7/8.
    After the close of trading Oracle (ORCL: Research, Estimates) fell 1-3/4 to 77. The maker of database software posted fiscal third-quarter net income of $498 million, or 17 cents per share, beating analysts' estimates.
    
The markets ahead

    Patrick Adams, president and portfolio manager at Choice Investment Management, told CNNfn's market coverage he sees the Dow and S&P 500, both down this year, catching up to the Nasdaq, which is still up about 16 percent year-to-date. (431K WAV) (431K AIFF)
    Still, 19 of the Dow's 30 stocks fell Tuesday. The biggest losers were Hewlett-Packard (HWP: Research, Estimates), which shed 6-1/2 to 140, and Alcoa, which lost 6-13/16 to 61-1/4.
    Alcoa, the world's largest aluminum company dropped after agreeing to buy aerospace industry supplier Cordant Technologies Inc. for $2.9 billion, including assumption of debt. Cordant (CDD: Research, Estimates) surged 25-1/2 to 55-1/16.
    In other deals, telecommunications equipment maker Nortel Networks  (NT: Research, Estimates) jumped 2-3/16 to 123-7/8 after agreeing to buy Xros, a maker of high-tech gear that helps transmit data using light, for $3.25 billion in stock.
    BP Amoco (BPA: Research, Estimates) fell 7/16 to 51-1/8 after agreeing to acquire British oil and lubricants maker Burmah Castrol in a $4.7 billion cash deal. American depositary receipts of Burmah Castrol (BURMY: Research, Estimates) jumped 8 to 40.
    Sears, Roebuck & Co. (S: Research, Estimates) rose 11/16 to 21-1/8 after the nation's No. 2 retailer and America Online (AOL: Research, Estimates), the nation's largest Internet service provider, announced an alliance to market each other's goods and services. AOL, which has agreed to buy Time Warner, the parent of CNNfn, gained 7/16 to 61-3/4. Time Warner  (TWX: Research, Estimates) advanced 5/8 to 87-1/8.
    In earnings news, Martha Stewart Living Omnimedia Inc. (MSO: Research, Estimates) lost 1/2 to 25-5/8 despite posting quarterly pro forma net income of $2.4 million, or 5 cents per diluted share, beating expectations.
    The flurry of mergers lifted the market earlier Tuesday, sparking optimism of more deals to come.
    
Strong retail sales

    Stocks early Tuesday also got a boost from the latest economic data showing U.S. retail sales rose 1.1 percent in February.
    Analysts said the news shows consumers continue to spend -- bolstering expectations for strong corporate profits -- but not at a rate that will force aggressive rate hikes by the Federal Reserve.
    "This tells us that inflation is in check," said Charles Payne, head analyst at Wall Street Strategies. "Even though consumers are spending, it's not reflected in the price of goods." Back to top

  RELATED STORIES

European markets regain some luster - Mar. 14, 2000

Asian markets fall again - Mar. 14, 2000

  RELATED SITES

Latest upgrades

Latest downgrades

Initiated coverage

Stock split calendar

IPO's

Earnings warnings

Economic calendar

View the latest market update via Netshow

See how your mutual funds are doing

Need investing advice? Try Quicken.com on fn

Track your stocks


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.